Non-invasive Imaging of Endothelial Progenitor Cells in Tumor Neovascularization Using a Novel Dual-modality Paramagnetic/Near-Infrared Fluorescence Probe

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Wang, Xin Yi ^a   Ju, Shenghong ^a   Li, Cong ^b   Peng, Xin Gui ^a   Chen, Alex F ^c   Mao, Hui ^d   Teng, Gao Jun ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GADOLINIUM; RHODAMINE; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL DENSITY; CELL DIFFERENTIATION; CELL HOMING; CELL LABELING; CELL MIGRATION; CELL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENDOTHELIAL PROGENITOR CELL; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MICROVASCULATURE; NEAR INFRARED SPECTROSCOPY; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RELAXATION TIME; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALS; BLOOD VESSELS; BONE MARROW CELLS; CARBOCYANINES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL CELLS; FEMALE; FLUORESCENT DYES; GADOLINIUM; HUMANS; INFRARED RAYS; MAGNETIC RESONANCE IMAGING; MAGNETS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOVASCULARIZATION, PATHOLOGIC; OPTICAL IMAGING; RATS; STAINING AND LABELING; STEM CELL TRANSPLANTATION;

MUS;

EID: 84870611178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050575     Document Type: Article

References (41)

1. Folkman J, (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
2. Janic B, Arbab AS, (2010) The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization. ScientificWorldJournal 10: 1088-1099.
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
4. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, et al. (2007) Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 21: 1546-1558.
5. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201.
6. Gao DC, Nolan D, McDonnell K, Vahdat L, Benezra R, et al. (2009) Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 1796: 33-40.
7. Urbich C, Dimmeler S, (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353.
8. Bagley RG, Weber W, Rouleau C, Teicher BA, (2005) Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. Cancer Res 65: 9741-9750.
9. Murakami J, Li TS, Ueda K, Tanaka T, Hamano K, (2009) Inhibition of accelerated tumor growth by blocking the recruitment of mobilized endothelial progenitor cells after chemotherapy. Int J Cancer 124: 1685-1692.
10. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, et al. (2005) Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11: 261-262.
11. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, et al. (2008) Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 105: 6620-6625.
12. Arbab AS, Pandit SD, Anderson SA, Yocum GT, Bur M, et al. (2006) Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 24: 671-678.
13. Tamura M, Unno K, Yonezawa S, Hattori K, Nakashima E, et al. (2004) In vivo trafficking of endothelial progenitor cells their possible involvement in the tumor neovascularization. Life Sci 75: 575-584.
14. Dome B, Dobos J, Tovari J, Paku S, Kovacs G, et al. (2008) Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 73: 186-193.
15. Ferrari N, Glod J, Lee J, Kobiler D, Fine HA, (2003) Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther 10: 647-656.
16. Ntziachristos V, Bremer C, Weissleder R, (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13: 195-208.
17. Koo V, Hamilton PW, Williamson K, (2006) Non-invasive in vivo imaging in small animal research. Cell Oncol 28: 127-139.
18. Ogawa M, Kosaka N, Choyke PL, Kobayashi H, (2009) In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res 69: 1268-1272.
19. Gioux S, Choi HS, Frangioni JV, (2010) Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 9: 237-255.
20. Li C, Penet MF, Winnard P Jr, Artemov D, Bhujwalla ZM, (2008) Image-guided enzyme/prodrug cancer therapy. Clin Cancer Res 14: 515-522.
21. Ju SH, Qiu YR, Li C, Teng GJ, Ni YC, (2011) Multimodality imaging of endothelial progenitor cells with a novel multifunctional probe featuring positive magnetic resonance contrast and near-infrared fluorescence. Mol Imaging 10: 359-369.
22. Mahan SD, Ireton GC, Knoeber C, Stoddard BL, Black ME, (2004) Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. Protein Eng Des Sel 17: 625-633.
23. Li C, Wildes F, Winnard P Jr, Artemov D, Penet MF, et al. (2008) Conjugation of poly-L-lysine to bacterial cytosine deaminase improves the efficacy of enzyme/prodrug cancer therapy. J Med Chem 51: 3572-3582.
24. Li C, Winnard PT Jr, Takagi T, Artemov D, Bhujwalla ZM, (2006) Multimodal image-guided enzyme/prodrug cancer therapy. J Am Chem Soc 128: 15072-15073.
25. Aoki M, Yasutake M, Murohara T, (2004) Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 22: 994-1002.
26. Hasegawa M, Sone S, Takashima S, Li F, Yang ZG, et al. (2000) Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 73: 1252-1259.
27. Liu ZF, Liu SL, Niu G, Wang F, Chen XY, (2010) Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers. Mol Imaging 9: 21-29.
28. Yao YY, Li YF, Ma GS, Liu NF, Ju SH, et al. (2010) In vivo magnetic resonance imaging of injected endothelial progenitor cells after myocardial infarction in rats. Mol Imaging Biol 13: 303-313.
29. Pendharkar AV, Chua JY, Andres RH, Wang N, Gaeta X, et al. (2010) Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 41: 2064-2070.
30. Bulte JW, Zhang S, van Gelderen P, Herynek V, Jordan EK, et al. (1999) Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 96: 15256-15261.
31. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, et al. (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19: 1141-1147.
32. Mai XL, Ma ZL, Sun JH, Ju SH, Ma M, et al. (2009) Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles. Cell Transplant 18: 171-181.
33. Puppi J, Mitry RR, Modo M, Dhawan A, Raja K, et al. (2011) Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes. Cell Transplant 20: 963-975.
34. Rehman J, Li J, Orschell CM, March KL, (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
35. Jain RK, (2005) Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307: 58-62.
36. Jain RK, Tong RT, Munn LL, (2007) Effect of vascular normalization, by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: Insights from a mathematical model. Cancer Res 67: 2729-2735.
37. Fukumura D, Jain RK, (2007) Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization. Microvascular Res 74: 72-84.
38. Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, et al. (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6: 553-563.
39. Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, et al. (2008) Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111: 1302-1305.
40. Varma NR, Janic B, Iskander AS, Shankar A, Bhuiyan MP, et al. (2012) Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human glioma. PLoS One 7: e30310.
41. Rad AM, Iskander AS, Janic B, Knight RA, Arbab AS, et al. (2009) AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study. BMC Biotechnol 9: 28.